Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


06.01.2025

4 Ann Surg Oncol
2 Anticancer Res
1 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Dermatol
1 Cancer
1 J Clin Oncol
1 N Engl J Med
1 Nat Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. MIURA JT, Karakousis GC
    Neoadjuvant Nivolumab and Ipilimumab for Resectable Stage III Melanoma: The New Standard of Care?
    Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16807.
    PubMed        

  2. LEE AH, Nessim C
    ASO Author Reflections: Do Biopsy Margins Really Matter in Melanoma?
    Ann Surg Oncol. 2024 Dec 31. doi: 10.1245/s10434-024-16804.
    PubMed        

  3. PAZHAVA A, Yu WY, Jing FZ, Hill S, et al
    ASO Visual Abstract: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16798.
    PubMed        

  4. PENNINGTON TE, Thompson JF, Varey AHR
    ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?
    Ann Surg Oncol. 2024 Dec 27. doi: 10.1245/s10434-024-16821.
    PubMed        


    Anticancer Res

  5. HASHIGUCHI S, Tanaka T, Mano R, Kondo S, et al
    SLC7A11/xCT-mediated Cystine Uptake Regulates Intracellular Glutathione and Promotes Antioxidant Defense in Lymphatic Endothelial Cells.
    Anticancer Res. 2025;45:65-71.
    PubMed         Abstract available

  6. HADDAD S, Weise JJ, Wagenpfeil S, Vogt T, et al
    Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor - Meta-analyses and Systematic Review.
    Anticancer Res. 2025;45:27-37.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  7. CHEN Y, Zhang L, Shi H, Shen Z, et al
    Thermosensitive hydrogel delivery of BCG lysates and tumor antigens: A novel strategy for melanoma immunoprevention and therapeutics.
    Biochem Biophys Res Commun. 2024;745:151215.
    PubMed         Abstract available


    BMC Cancer

  8. BORILOVA S, Grell P, Selingerova I, Gescheidtova L, et al
    Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer.
    BMC Cancer. 2024;24:1590.
    PubMed         Abstract available


    Br J Dermatol

  9. PLACKE JM, Bottek J, Varaljai R, Shannan B, et al
    Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.
    Br J Dermatol. 2024 Dec 31:ljae433. doi: 10.1093.
    PubMed         Abstract available


    Cancer

  10. PASSMAN JE, Kallan MJ, Roberson JL, Ginzberg SP, et al
    Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.
    Cancer. 2025;131:e35664.
    PubMed         Abstract available


    J Clin Oncol

  11. HUANG RY, Youssef G, Nelson T, Wen PY, et al
    Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.
    J Clin Oncol. 2025 Jan 3:JCO2400953. doi: 10.1200/JCO.24.00953.
    PubMed         Abstract available


    N Engl J Med

  12. CURTI BD
    Checkpoint Immunotherapy for Melanoma - Offering Hope for Cure.
    N Engl J Med. 2025;392:81-82.
    PubMed        


    Nat Med

  13. BORGERS JSW, Lenkala D, Kohler V, Jackson EK, et al
    Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03418.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.